Avantor, Inc. (AVTR)
$
10.92
+0.11 (1.01%)
Key metrics
Financial statements
Free cash flow per share
0.7681
Market cap
7.4 Billion
Price to sales ratio
1.1323
Debt to equity
0.6926
Current ratio
1.4884
Income quality
-4.4969
Average inventory
787.6 Million
ROE
-0.0138
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Avantor, Inc. serves various sectors, including biopharma, healthcare, education, government, advanced technologies, and applied materials across the Americas, Europe, Asia, the Middle East, and Africa. The company displays a robust financial profile, with a net income ratio of 0.10 illustrating its profitability margin. Additionally, the reported depreciation and amortization expenses are $405,500,000.00 pointing to the wear and tear of its substantial asset base. With an operating income ratio of 0.16 the firm showcases sound operational profitability. Furthermore, the weighted average number of diluted shares outstanding is 681,900,000.00 reflecting the potential dilution effects on shareholder value. Moreover, the company's selling, general, and administrative expenses amount to $1,641,100,000.00 indicative of its operational overhead costs. Avantor offers a comprehensive array of materials and consumables, such as purity chemicals and reagents, lab products, and tailored solutions like customized excipients and process chromatography resins. The equipment and instrumentation products include filtration systems and biological safety cabinets, paired with essential services in lab and production settings. In terms of investment appeal, the stock is affordable at $12.50 making it suitable for budget-conscious investors. The stock exhibits a high average trading volume of 10,384,961.00 which indicates strong liquidity, a vital characteristic for active participants in the market. With a mid-range market capitalization of $7,445,418,260.00 the company stands as a steady performer within its respective sectors. Recognized as a key player in the Medical - Instruments & Supplies industry, Avantor contributes significantly to the overall market landscape, providing innovative solutions that drive growth. It operates within the Healthcare sector, where it continues to lead and foster advancements in its field.
Is Avantor, Inc. (AVTR) a good investment?
Investing in Avantor, Inc. (AVTR) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bearish outlook. Always conduct your own research before investing.
What is Avantor, Inc. (AVTR)'s stock forecast?
Analysts predict Avantor, Inc. stock to fluctuate between $10.62 (low) and $22.44 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Avantor, Inc.'s market capitalization?
As of 2026-01-30, Avantor, Inc.'s market cap is $7,445,418,260, based on 681,814,859 outstanding shares.
How does Avantor, Inc. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Avantor, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Avantor, Inc. (AVTR) stock?
To buy Avantor, Inc. (AVTR) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AVTR. Place an order (Market, Limit, etc.).
What is the best time to invest in Avantor, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
How did Avantor, Inc. perform in the last earnings report?
Revenue: $6,783,600,000 | EPS: $1.05 | Growth: 118.75%.
Where can I find Avantor, Inc.'s investor relations reports?
Visit https://www.avantorsciences.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Avantor, Inc.?
You can explore historical data from here
What is the all-time high and low for Avantor, Inc. stock?
All-time high: $44.37 (2021-09-23) | All-time low: $10.62 (2025-12-08).
What are the key trends affecting Avantor, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
prnewswire.com
NEW YORK, Jan. 28, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Avantor, Inc. (NYSE: AVTR) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Avantor caused the company to misrepresent or fail to disclose that: (1) Avantor's competitive positioning was weaker than had been publicly represented; (2) Avantor was experiencing negative effects from increased competition; and (3) as a result, representations about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.
newsfilecorp.com
New York, New York--(Newsfile Corp. - January 15, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Avantor, Inc. (NYSE: AVTR) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Avantor caused the company to misrepresent or fail to disclose that: (1) Avantor's competitive positioning was weaker than had been publicly represented; (2) Avantor was experiencing negative effects from increased competition; and (3) as a result, representations about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.
seekingalpha.com
Avantor, Inc. (AVTR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
businesswire.com
CHICAGO--(BUSINESS WIRE)-- #Biotech--Trial will demonstrate advanced traceability of drugs for Oncology, Urology, Rheumatology and Gastroenterology across pharmaceutical supply chain.
zacks.com
AVTR looks worth holding as its broad portfolio, strategic deals and cost savings offset Lab Solutions' weakness for now with AI tools and strong cash flow.
fool.com
Chicago-based Kinney Asset Management increased its Avantor position by 470,000 shares in the third quarter. The overall position value went up by about $4.52 million compared to the previous period.
globenewswire.com
NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Avantor, Inc. ("Avantor, Inc." or the "Company") (NYSE: AVTR) of a class action securities lawsuit.
globenewswire.com
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Avantor (AVTR) To Contact Him Directly To Discuss Their Options
businesswire.com
NEW YORK--(BUSINESS WIRE)---- $AVTR #AVTR--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) and reminds investors of the December 29, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has.
globenewswire.com
LOS ANGELES, Dec. 29, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Avantor, Inc., (“Avantor” or the "Company") (NYSE: AVTR) investors of a class action on behalf of investors that bought securities between March 5, 2024 and October 8, 2025, inclusive (the “Class Period”). Avantor investors have until December 29, 2025 to file a lead plaintiff motion.
See all news
